All Posts:SARS-CoV-2
-
Researchers Find Humans Have Given Wild Animals Their Diseases Nearly 100 Times
WASHINGTON (March 23, 2022) — An international research team led by scientists at Georgetown University has found that humans might give viruses back to animals more often than previously understood. In a study published March 22 in Ecology Letters (“Assessing the risk of human-to-wildlife pathogen transmission for conservation and public health”), the authors describe nearly […]
Category: News Release
-
Researchers Use Artificial Intelligence to Guide the Search for the Next SARS-like Virus
WASHINGTON (January 10, 2022) — An international research team led by scientists at Georgetown University has demonstrated the power of artificial intelligence to predict which viruses could infect humans — like SARS-CoV-2, the virus that led to the COVID-19 pandemic — which animals host them, and where they could emerge. Their ensemble of predictive models […]
Category: News Release
-
Statement from Jesse L. Goodman, MD, MPH, on FDA Approval of Pfizer-BioNTech’s COVID-19 Vaccine
WASHINGTON (August 23, 2021) — Today, the U.S. Food & Drug Administration approved the two-dose COVID-19 Pfizer-BioNTech vaccine. Jesse L. Goodman, MD, MPH, professor of medicine and infectious diseases at Georgetown University Medical Center and former FDA Chief Scientist, shares the following comments: “In addition to evaluating the vaccine’s safety and efficacy in preventing COVID, FDA has […]
Category: News Release
-
Vaccines Alone May Not Be Enough to End Pandemic
WASHINGTON (March 18, 2021) — Even as vaccines are becoming more readily available in the U.S., protecting against the asymptomatic and pre-symptomatic spread of the virus (SARS-CoV-2) that causes COVID-19 is key to ending the pandemic, say two Georgetown infectious disease experts. In their Perspective, “SARS-CoV-2 Transmission Without Symptoms,” published March 18 in the journal […]
Category: News Release
-
Shutting Down COVID-19 Virus’s Destructive Proteins with Aerosolized Molecules
WASHINGTON (November 13, 2020) — Researchers at Georgetown University Medical Center have successfully used molecules comprised of small strands of RNA to shut down the production of destructive proteins generated by the COVID-19 virus. Additionally, the researchers are working to aerosolize the RNA molecules so that they could be incorporated in an inhalable drug that […]
Category: News Release
-
Georgetown Applying Patented Technology to Develop Fast and Accurate COVID-19 Test
(August 6, 2020) — After studying the results of a myriad of diagnostic tests used around the world for the virus SARS-CoV-2, which causes COVID-19, Georgetown University Medical Center biochemist Mark Danielsen, PhD, thinks he has a solution for making a better test — one that can deliver faster results and be accurate. It’s a […]
Category: GUMC Stories
-
Medical Student Makes a Difference by Donating Convalescent Plasma
(July 17, 2020) — When Tanvee Singh (M’22) started feeling sick in March, she thought her asthma was acting up. As her symptoms worsened, she was diagnosed with COVID-19, the disease caused by the novel coronavirus. Determined to find a silver lining in her experience, Singh donated plasma at the NIH Clinical Center when she […]
Category: GUMC Stories
-
Conditional Reprogramming: A Novel Way to Study the Novel Coronavirus
(July 8, 2020) — Even during the early days of the pandemic, it was apparent that some patients with COVID-19 develop multisystem problems in addition to respiratory infections. Specifically, the virus can cause life-threatening gastrointestinal, cardiac, neurological and renal complications. These severe cases appear to occur because the virus rapidly replicates in various organs, causing […]
Category: GUMC Stories
-
Dearth of Medical Resources in Africa for COVID-19 Reminiscent of Early HIV/AIDS Pandemic
WASHINGTON (May 7, 2020) — “We have seen this before.” Global health scholars have issued a clarion call about the needless loss of life expected because of a foreseeable prospect of “slow and inadequate access to supplies” to control COVID-19 in sub-Saharan Africa. They say what is unfolding now is similar to when lifesaving diagnostics […]
Category: News Release
-
Georgetown University Medical Center and MedStar Georgetown University Hospital Collaborate on COVID-19 Antibody Study
WASHINGTON (May 7, 2020) — Georgetown University Medical Center, in collaboration with MedStar Georgetown University Hospital, is conducting a study to test for antibodies in two groups of people with increased vulnerability to COVID-19: hospital workers and those with cancer. The FDA has approved (under an emergency use authorization) only a few tests produced commercially […]
Category: News Release